## Abstract ## __Background.__ Screening for synchronous pulmonary tumors in patients presenting with squamous cell carcinoma of the head and neck (SCCHN) is important, because detection may alter subsequent management. ## __Methods.__ We conducted a retrospective review, comparing effectiveness
18F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma
✍ Scribed by Stephan K. Haerle; Klaus Strobel; Thomas F. Hany; Daniel Sidler; Sandro J. Stoeckli
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 125 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background.
This study assesses the additional value of ^18^F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography/CT (^18^F‐FDG‐PET/CT) with respect to synchronous primaries in patients undergoing panendoscopy for staging of head and neck squamous cell carcinoma.
Methods.
In all, 311 patients underwent both modalities. Cytology, histology, and/or clinical/imaging follow‐up served as reference standard.
Results.
The prevalence of second primary tumors detected by panendoscopy was 4.5%, compared with 6.1% detected by ^18^F‐FDG‐PET/CT. The sensitivity for panendoscopy was 74%, the specificity was 99.7%, the positive predictive value (PPV) was 93%, and the negative predictive value (NPV) was 98%. The sensitivity for ^18^F‐FDG‐PET/CT was 100%, the specificity was 95.7%, the PPV was 59%, and the NPV was 100%.
Conclusions.
^18^F‐FDG‐PET/CT is superior to panendoscopy. With a negative ^18^F‐FDG‐PET/CT, the extent of endoscopy can be reduced to the area of the primary tumor. Due to the costs, ^18^F‐FDG‐PET/CT is recommended only in advanced disease to assess potential distant disease. In early‐stage cancer, panendoscopy is accurate enough to rule out secondary tumors. © 2009 Wiley Periodicals, Inc. Head Neck, 2010
📜 SIMILAR VOLUMES
## Abstract ## Background. A disadvantage of 2‐[^18^F]fluoro‐2‐deoxy‐D‐glucose (^18^F‐FDG) positron emission tomography (PET) in head and neck cancer is that ^18^F‐FDG uptake is not specific to malignant tissue. To provide an alternative, radiolabeled amino acids such as L‐1‐[^11^C]‐tyrosine (^11^
## Abstract ## Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial. ## Methods In all, 20 sub